 | Up a level |
2018
Festag, M., Wisskirchen, K., Hasreiter, J., Schreiber, S., Abken, H. and Protzer, U. (2018). EVALUATION OF A FULLY HUMAN CAR FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION IN AN IMMUNOCOMPETENT MOUSE MODEL. Hum. Gene Ther., 29 (11). S. A4 - 1. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1557-7422
Schirmer, D., Storz, I., Wisskirchen, K., Feederle, R., Schmidt, O., Abken, H., Protzer, U., Burdach, S. and Richter, G. (2018). GPR64-specific CAR-trnasgenic T cells selectively kill Ewing sarcoma cells. Oncol. Res. Treat., 41. S. 130 - 131. BASEL: KARGER. ISSN 2296-5262
2014
Krebs, K., Boettinger, N., Huang, L., Chmielewski, M., Uckert, W., Abken, H., Heikenwaelder, M., Knolle, P. and Protzer, U. (2014). T CELLS REDIRECTED BY A CHIMERIC ANTIGEN RECEPTOR RECOGNIZING HBSAG EFFICIENTLY CONTROL HBV IN VIVO IN TRANSGENIC MICE. Cytotherapy, 16 (4). S. S9 - 1. OXFORD: ELSEVIER SCI LTD. ISSN 1477-2566
Xia, Y., Stadler, D., Lucifora, J., Reisinger, F., Webb, D., Feuerherd, M., Hoesel, M., Bohne, F., Heikenwaelder, M. and Protzer, U. (2014). INTERFERON gamma AND TUMOR NECROSIS FACTOR alpha TREATMENT INDUCE COVALENTLY CLOSED CIRCULAR DNA DEGRADATION IN HEPATITIS B VIRUS INFECTED HEPATOCYTES. J. Hepatol., 60 (1). S. S41 - 1. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1600-0641